Effects of cognitive impairment on substance abuse treatment attendance: Predictive validation of a brief cognitive screening measure

American Journal of Drug and Alcohol Abuse

Volumn 38, Issue 3, 2012, Pages 246-250

  Copersino, Marc L ^a,b   Schretlen, David J ^c   Fitzmaurice, Garrett M ^a,b,d   Lukas, Scott E ^a,b   Faberman, Judith ^a,b   Sokoloff, Jody ^a   Weiss, Roger D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

addiction; cognitive screening measure; Montreal Cognitive Assessment; substance use disorder

Indexed keywords

ADULT; ARTICLE; BEHAVIOR; COGNITIVE DEFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; PREDICTION; SUBSTANCE ABUSE; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PSYCHOTHERAPY, GROUP; SUBSTANCE-RELATED DISORDERS;

EID: 84859708036     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2012.670866     Document Type: Article

References (24)

1. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006; 81 (3):313-322.
2. Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitivebehavioral treatment. Drug Alcohol Depend 2003; 71 (2):207-211.
3. Donovan DM, Kivlahan DR, Kadden RM, Hill D. Cognitive impairment as a patient-treatment matching hypothesis. In Project MATCH Hypothesis: Results and Causal Chain Analyses. Longabaugh R, Wirtz, PW, eds. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 2001; 62-81.
4. Katz EC, King SD, Schwartz RP, Weintraub E, Barksdale W, Robinson R, Brown, BS. Cognitive ability as a factor in engagement in drug abuse treatment. Am J Drug Alcohol Abuse 2005; 31(3): 359-369.
5. Blume AW, Schmaling KB, Marlatt GA. Memory, executive cognitive function, and readiness to change drinking behavior. Addict Behav 2005; 30(2):301-314.
6. Bates ME, Pawlak AP, Tonigan JS, Buckman JF. Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol Addict Behav 2006; 20(3): 241-253.
7. Rinn W, Desai N, Rosenblatt H, Gastfriend DR. Addiction denial and cognitive dysfunction: A preliminary investigation. J Neuropsychiatry Clin Neurosci 2002; 14(1):52-57.
8. Smith DE, McCrady BS. Cognitive impairment among alcoholics: Impact on drink refusal skill acquisition and treatment outcome. Addict Behav 1991; 16(5):265-274.
9. Aharonovich E, Amrhein PC, Bisaga A, Nunes EV, Hasin DS. Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychol Addict Behav 2008; 22(4):557-562.
10. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4):695-699.
11. Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol 2009; 17(5):337-344.
12. Simpson DD, Joe GW, Rowan-Szal GA, Greener JM. Drug abuse treatment process components that improve retention. J Subst Abuse Treat 1997; 14(6):565-572.
13. Blonigen DM, Timko C, Finney JW, Moos BS, Moos RH. Alcoholics Anonymous attendance, decreases in impulsivity and drinking and psychosocial outcomes over 16 years: Moderated-mediation from a developmental perspective. Addiction 2011; 106(12):2167-2177.
14. Bogenschutz MP, Tonigan JS, Miller WR. Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change. J Stud Alcohol 2006; 67(4):562-567.
15. Wu LT, Pan JJ, Blazer DG, Tai B, Stitzer ML, Brooner RK, Woody GE, Patkar AA, Blaine JD. An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs 2009; 70(3):414-425.
16. Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. LittenRZ, Allen JP, eds. Totowa,NJ: Humana Press, 1992; 41-72.
17. Patterson F, Jepson C, Kaufmann V, Rukstalis M, Audrain-McGovern J, Kucharski S, Lerman C. Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. Drug Alcohol Depend 2003; 72(2): 123-131.
18. Vik PW, Cellucci T, Jarchow A, Hedt J. Cognitive impairment in substance abuse. Psychiatr Clin North Am 2004; 27(1): 97-109, ix.
19. Jones HE, Haug N, Silverman K, Stitzer M, Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend 2001; 61(3):297-306.
20. Lott DC, Jencius S. Effectiveness of very low-cost contingency management in a community adolescent treatment program. Drug Alcohol Depend 2009; 102(1-3):162-165.
21. De Castro S, Sabate E. Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers. Clin Infect Dis 2003; 37(Suppl. 5):S464-S467.
22. Corrigan JD, Bogner J, Lamb-Hart G, Heinemann AW, Moore D. Increasing substance abuse treatment compliance for persons with traumatic brain injury. Psychol Addict Behav 2005; 19(2):131-139.
23. Miller L. Neuropsychological assessment of substance abusers: Review and recommendations. J Subst Abuse Treat 1985; 2(1):5-17.
24. Parsons OA, Farr SP. The neuropsychology of alcohol and drug use. In Handbook of Clinical Neuropsychology. Filskov SB, Boll TJ, eds. New York: Wiley, 1981; 320-365.